Showing results (41-50 of 403) with videos related to
Sort By:
Pageof 41
Epilepsy & Behavior : E&B|October 7, 2003
Translating monotherapy trials into clinical practice: a look into the abyssSantiago Arroyo, Emilio PeruccaDrugs|August 3, 2019
Pharmacological and Therapeutic Properties of Cannabidiol for EpilepsyValentina Franco, Emilio PeruccaCNS Drugs|January 24, 2025
Targeting Kv7 Potassium Channels for EpilepsyEmilio Perucca, Maurizio TaglialatelaEpilepsia Open|March 29, 2018
Not all that glitters is gold: A guide to the critical interpretation of drug trials in epilepsyEmilio Perucca, Samuel WiebeEpilepsia|May 27, 2020
Does cannabidiol have antiseizure activity independent of its interactions with clobazam? An appraisal of the evidence from randomized controlled trialsMeir Bialer, Emilio PeruccaExpert Opinion on Drug Metabolism & Toxicology|June 4, 2015
CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effectsValentina Franco, Emilio PeruccaDrugs|March 1, 2026
Antiseizure Medications that Did Not Reach the Epilepsy Market: An Assessment of Factors Contributing to Their Failed Clinical Development Over the Last Three DecadesMeir Bialer, Emilio PeruccaCNS Drugs|June 7, 2020
Critical Aspects Affecting Cannabidiol Oral Bioavailability and Metabolic Elimination, and Related Clinical ImplicationsEmilio Perucca, Meir BialerCurrent Opinion in Neurology|November 16, 2004
Epilepsy after head injuryRaimondo D'Ambrosio, Emilio PeruccaExpert Review of Neurotherapeutics|September 2, 2015
The pharmacogenomics of epilepsyValentina Franco, Emilio PeruccaPageof 41